Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-03-01

FDA Approved: DEFERASIROX — Supplemental Application (Dr. Reddy's Laboratories Inc)

View source ↗

Summary

The FDA approved a supplemental application for Deferasirox submitted by Dr. Reddy's Laboratories Inc, resulting in changes to the product's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Deferasirox (Deferasirox)

Snippet

SUPPL AP for DEFERASIROX (DEFERASIROX)